<DOC>
	<DOCNO>NCT00643500</DOCNO>
	<brief_summary>Patients partial-onset seizure see community-based practice include therapeutic use study - ass safety tolerability Keppra ( Levetiracetam ) confirm favorable safety drug find clinical development - obtain information optimal dose daily clinical practice . Compared previous registration trial , study population correspond closely see daily clinical practice .</brief_summary>
	<brief_title>Pharmacovigilance Study Keppra . SPAIN - SKATE : Safety Keppra Adjunctive Therapy Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<criteria>Male female old 16 year ; Epilepsy partial onset seizure , without secondary generalization ; At least one concomitant market antiepileptic drug Safety reason</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>